Loading...
XSHE
000790
Market cap345mUSD
Sep 22, Last price  
3.89CNY
1D
-2.23%
1Q
6.49%
Jan 2017
-57.22%
Name

Chengdu Huasun Technology Group Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
2.81
EPS
—
Div Yield, %
0.25%
Shrs. gr., 5y
1.65%
Rev. gr., 5y
3.00%
Revenues
864m
-13.89%
187,758,119223,849,032275,663,873363,187,884380,877,510489,033,441551,511,666580,530,915657,809,857528,216,541463,311,851575,194,221590,948,888633,417,693745,340,799759,307,481954,939,781873,103,0221,003,376,636863,976,571
Net income
-7m
L
2,214,5925,401,0621,845,6995,109,2607,204,70712,479,65320,841,54333,671,31850,062,29466,093,057082,497,356171,667,02131,169,35261,632,30237,503,53155,634,83241,217,51827,659,463-6,690,166
CFO
64m
+35.57%
22,353,85118,561,9842,107,33912,003,34729,603,131116,005,68759,965,333034,850,0550051,590,6270107,736,44365,027,23813,495,8000155,887,75147,414,10464,278,831
Dividend
Jul 26, 20240.01 CNY/sh

Profile

Chengdu Huasun Technology Group Inc., Ltd. manufactures and sells medicines, bio-pharmaceutical products, and building steel structures. The company manufactures modern Chinese medicines, traditional Chinese medicines, and chemical medicines; and sells drugs. It also engages in the research and development, production, and sale of biological products and biotechnology drugs; and medicines for the treatment of cardiovascular and cerebrovascular diseases. In addition, the company designs, produces, installs, and services steel structure buildings. The company was formerly known as Chengdu Taihe Health Technology Group Inc., Ltd. and changed its name to Chengdu Huasun Technology Group Inc., Ltd. in April 2020. Chengdu Huasun Technology Group Inc., Ltd. was founded in 1998 and is based in Chengdu, China.
URL
http://www.huasungrp.com/
IPO date
Mar 27, 1998
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
863,977
-13.89%
1,003,377
14.92%
873,103
-8.57%
Cost of revenue
733,055
856,248
754,943
Unusual Expense (Income)
NOPBT
130,922
147,128
118,160
NOPBT Margin
15.15%
14.66%
13.53%
Operating Taxes
10,300
(329)
7,842
Tax Rate
7.87%
6.64%
NOPAT
120,622
147,458
110,318
Net income
(6,690)
-124.19%
27,659
-32.89%
41,218
-25.91%
Dividends
(20,702)
(6,281)
(6,256)
Dividend yield
0.79%
0.18%
0.22%
Proceeds from repurchase of equity
(10,138)
(1,638)
(1)
BB yield
0.39%
0.05%
0.00%
Debt
Debt current
398,461
276,353
91,441
Long-term debt
94,613
32,710
117,547
Deferred revenue
1,357
2,438
3,520
Other long-term liabilities
73,227
69,236
14,915
Net debt
56,189
(128,848)
(260,442)
Cash flow
Cash from operating activities
64,279
47,414
155,888
CAPEX
(141,955)
(189,308)
Cash from investing activities
(146,162)
(243,105)
Cash from financing activities
83,649
274,724
85,854
FCF
(54,039)
34,696
102,240
Balance
Cash
216,027
211,180
144,638
Long term investments
220,858
226,732
324,792
Excess cash
393,686
387,743
425,775
Stockholders' equity
1,025,255
881,632
950,754
Invested Capital
1,227,674
1,053,033
720,929
ROIC
10.58%
16.62%
15.99%
ROCE
8.00%
10.10%
10.26%
EV
Common stock shares outstanding
669,017
691,487
618,538
Price
3.90
-22.92%
5.06
11.21%
4.55
-28.46%
Market cap
2,609,165
-25.43%
3,498,922
24.32%
2,814,349
-28.21%
EV
2,707,439
3,539,629
2,556,326
EBITDA
170,744
181,845
152,365
EV/EBITDA
15.86
19.47
16.78
Interest
20,662
9,949
4,280
Interest/NOPBT
15.78%
6.76%
3.62%